INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Medical Vials-GettyImages-547146854]( "Microbial Challenge In-Use Studies")
Microbial Challenge In-Use StudiesLearn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
![GettyImages-1359868760 Syringe, Ampuoles, And Vials]( "Long-Acting Injectables Stratµm")
Long-Acting Injectables StratµmLong-acting injectables have clinical value, and Adare Pharma Solutions' Stratµm technology offers tangible value for certain applications. Patients can now experience improved outcomes and comfort with injectables.
-
![stevanato 1]( "Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications")
Solutions In Pre-Filled Syringes For Biologics And Ophthalmic ApplicationsDiscover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
-
![GettyImages-1470034194-magnifying-glass-charts-calculator]( "Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators")
Economic Advantage Of Robotic Gloveless Pharmaceutical IsolatorsAre robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Maintaining Sterility Through Precise Component Design And Manufacture2/4/2026
Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.
-
Solving The Silicone Challenge In Pre-Fillable Syringes8/27/2024
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
Bulk Filling Of Drug Substance | Accurate Aliquoting4/24/2024
Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to adjust pump controls to achieve accurate filling. This method, spanning multiple shifts, increases process risk through errors that can compromise accuracy.
-
NanoImprove The Performance Of Your Formulations9/24/2024
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future9/16/2025
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Filamatic Filler, Model AB-5]( "Used Filamatic Pharmaceutical Aseptic Filling System")
Used Filamatic Filler, Model AB-5, with fill piston and filling nozzle, 110 volt, serial# 022578.
-
![Allegro Bulk Fill]( "An Automated Filtration And Bulk Filling System")
Discover an automated filtration and filling system designed to accurately and aseptically aliquot bulk product into multiple biocontainers or bottles.
-
![syringe vaccine]( "Syringe Forming Lines")
Syringes are complex products that require an extremely precise forming process: Stevanato Group syringe manufacturing lines include several specifications, which are normally optional, such as servomotors for controlling the most critical manufacturing phases (cone forming, total length) and flow meters for automatically regulating the burners.
-
![cell and gene]( "Cell And Gene Therapy Development Aseptic R&D Filling Equipment")
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
![Uhlmann C 2205 Cartoner]( "Used Uhlmann Pharmaceutical Cartoner: C2205 Model")
Used Uhlmann horizontal cartoner, model C 2205, speeds up to 250/ minute, 150 mm x 100 mm x 90mm max cartoner size, dual blister feeder stations, with (1) powered and (1) drop feeder, Laetus scanner, 3/60/480, serial# 104, built 1994.
